Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.
Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.
We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.
In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months. Request Insights
Leadless pacemakers are medical devices which are used for the treatment of patients suffering from heart related diseases such as brady-arrythmias and slow heart rhythms. These are complete enclosed capsules which include pacemaker electronics and power source. Further, leadless pacemakers are implantable devices transplanted directly in the right ventricle of the heart where it sends small electrical impulses to the heart muscles to continue at an acceptable heart rate. Additionally, leadless pacemakers are less invasive as compared to traditional pacemakers and can be implanted within an hour. Leadless pacemakers take less time to recover and also eliminate problems related to transvenous leads such as lead fracture, insulation breaks and other. Leadless pacemakers produce comparatively less radiation and have better life quality without causing any infection to the heart ventricle.
The global leadless pacemakers market is expected to witness a robust growth over the forecast period i.e. 2017-2024. Rising heart related diseases across the globe and rising adoption of highly advanced medical devices in healthcare sector is envisioned to foster the growth of global leadless pacemakers market during the forecast period.
In terms of region, global leadless pacemakers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Among these regions, North America is the biggest market in leadless pacemakers and is anticipated to witness a robust growth over the forecast period owing to factors such as rising number of people suffering from heart related diseases and growing adoption of leadless pacemakers in healthcare sector in this region. In United States of America alone, more than 70% pacemakers’ implantations have been done in recent past. Further, North America region is expected to behold this positive growth over the forecast period.CLICK TO DOWNLOAD FREE SAMPLE
Asia Pacific region is projected to witness a remarkable growth over the forecast period owing to factors such as development of new medical industries and increasing investment in healthcare sector in this region. Additionally, factors such as rapid advancement in healthcare infrastructure and medical sector in Europe region is expected to drive the growth of leadless pacemakers market in this region.
Our-in depth analysis of the global leadless pacemakers market includes the following segments:
Global leadless pacemakers market is further classified on the basis of region as follows:
Global leadless pacemakers market is primarily driven by factors such as rising number of individuals suffering from heart related diseases such as bradycardia and others. Additionally, rapid failure of conventional pacemakers is also propelling the demand for leadless pacemakers which are comparatively effective in heart related diseases.
Further, additional advantages with implementation of leadless pacemakers such as lack of lead related complications and avoidances of pocket related problems such as infection, disfigurement and elimination of lead fracture are some of the major factors which are driving the growth of global leadless pacemakers market. Moreover, leadless pacemakers offer more convenience including less implementation time (less than an hour), less invasive and less recovery time. Such factors are expected to propel the demand for leadless pacemakers in healthcare sector.
However, high cost of leadless pacemakers (more than ten times of conventional pacemakers) may dampen the growth of global leadless market in near future.
Some other prominent vendors that may enter into manufacturing of leadless pacemaker are:
Related Reports
Disclaimer | Privacy Policy | Terms & Conditions
Copyright © 2021 Research Nester. All Rights Reserved
